Prognostication of Oxygen Requirement in Non-severe SARS-CoV-2 Infection (PRIORITISE)
Sponsor: Foundation for Innovative New Diagnostics, Switzerland
A observational or N/A phase clinical study on COVID and SARS-CoV2, this trial is ongoing. The trial is conducted by Foundation for Innovative New Diagnostics, Switzerland and has accumulated 12 data snapshots since 2020. Infectious disease trials contribute critical data for public health response and treatment development.
Status Flow
Change History
12 versions recorded-
Sep 2025 — Present [monthly]
Unknown
-
Sep 2024 — Sep 2025 [monthly]
Unknown
-
Jul 2024 — Sep 2024 [monthly]
Unknown
Status: Unknown Status → Unknown
-
Mar 2023 — Jul 2024 [monthly]
Unknown Status
Status: Recruiting → Unknown Status
-
Dec 2021 — Mar 2023 [monthly]
Recruiting
▶ Show 7 earlier versions
-
Oct 2021 — Dec 2021 [monthly]
Recruiting
-
Mar 2021 — Oct 2021 [monthly]
Recruiting
Status: Not Yet Recruiting → Recruiting
-
Jan 2021 — Mar 2021 [monthly]
Not Yet Recruiting
-
Nov 2020 — Jan 2021 [monthly]
Not Yet Recruiting
-
Sep 2020 — Nov 2020 [monthly]
Not Yet Recruiting
-
Aug 2020 — Sep 2020 [monthly]
Not Yet Recruiting
-
Jul 2020 — Aug 2020 [monthly]
Not Yet Recruiting
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Foundation for Innovative New Diagnostics, Switzerland
- International Centre for Diarrhoeal Disease Research, Bangladesh
- Mahidol Oxford Tropical Medicine Research Unit
- Medecins Sans Frontieres, Spain
For direct contact, visit the study record on ClinicalTrials.gov .